Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Aromatase Inhibitors × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Polycystic Ovary Syndrome 1 Neoplasm Metastasis 1 Hormone Receptor Positive Breast Carcinoma 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Arthralgia 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 4 Letrozole 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 palbociclib 2 talazoparib 1 pyrotinib 1 olaparib 1 eribulin 1 elacestrant 1 disitamab vedotin 1 dalpiciclib 1 abemaciclib 1 Vinorelbine 1 Sirolimus 1 Safety 1 Ritonavir 1 Itraconazole 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04227327 2025-07-29

HERMIONE-7

University of Milano Bicocca

Phase 2 Terminated

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡